| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |